ZURA
Zura Bio Ltd
NASDAQ · Healthcare · Biotechnology · US
$4.46
−2.41%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.22
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.21
- EPS estimate
- -$0.19
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -55.5%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $21
- PT range
- $20 – $22
- Analysts
- 3
3 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.19 | -$0.21 | Miss -9.78% | — |
| May 7, 2026 | -$0.17 | -$0.22 | Miss -29.41% | — |
| Mar 19, 2026 | -$0.18 | -$0.49 | Miss -172.22% | — |
| Nov 13, 2025 | -$0.19 | -$0.21 | Miss -10.53% | — |
| Aug 14, 2025 | -$0.19 | -$0.17 | Beat 10.53% | — |
| May 8, 2025 | -$0.17 | -$0.19 | Miss -11.76% | — |
| Mar 25, 2025 | -$0.16 | -$0.08 | Beat 50.00% | $2.0K |
| Nov 7, 2024 | -$0.14 | -$0.26 | Miss -85.71% | — |
| May 9, 2024 | -$0.23 | -$0.02 | Beat 91.30% | — |
| Aug 14, 2023 | -$0.25 | -$1.31 | Miss -424.00% | — |
| May 12, 2023 | -$2.76 | -$2.76 | In line | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026